Your Search Results

      • Trusted Partner

        OMNI Learning Guide to Reading Comprehension Strategies

        by Lorraine Gerstl

        I know I should read more, but I’m so busy, it takes time to read, and so much of what I try to read doesn’t really make that much sense to me …” Those can be the words of a third grader or, just as easily, the words of an adult. In our hurry-up world of bits and bytes, and the need for instant gratification, the sad and simple truth is that people don’t read as much as they used to and, more tragic, they understand what they read far less than in the past.In this practical, hands-on Guide, the author, a Master Teacher with more than thirty-five years of practical success teaching both children and adults of all ages, shares her Ideas on teaching reading comprehension strategies! The underlying message she delivers is: Comprehensive Strategies are important because Reading is an Active, not a Passive, Process.Reading can seem incredibly complicated. It involves not only making sense of the squiggles on a page – deciphering the alphabetic code and figuring out the words, but reading also entails giving meaning to, understanding, and thereby enjoying what we read.Reading comprehension is absolutely critical to communication, whether it involves a doctor healing a patient, a lawyer presenting an argument in court, an astronaut needing to know how to repair a malfunction when he is thousands of miles above the earth, or, most important, enriching and widening the scope of your life! In fact, you cannot think of one area of learning or practice where understanding what you read is not absolutely essential.The more you understand what you read, the less of a drudgery and the more of a joy it becomes. Reading is the key that unlocks the door to the universe.Get ready to start a great adventure – and to grab hold of the key that will unlock the door to your universe!Lorraine Gerstl is truly a woman for all seasons! She taught deaf children in her native South Africa before emigrating to the United States, where she raised her own children, then recommenced her teaching career at Briarcliff Academy / Robert Louis Stevenson before moving to Santa Catalina for nearly three decades as its beloved third-grade teacher. Since her “retirement” in 2017, she formed a partnership with Margie Lotz, a colleague from Santa Catalina: Omni Learning Center, which provides educational enrichment for homeschoolers. Lorraine has produced, directed, and acted in plays, musicals, variety shows, picked up a National Disney Teacher of the Year nomination, and traveled a good slice of the world in the process. An editor and internationally published writer, who won’t hesitate to stretch her students’ reach to the stars, she still revels in her favorite title – “Mom.” 76 Pages, Published by OMNI Learning Center Educational Guides,2020.______________OMNI Learning Center Educational Guides: Guide to Study for Success, Guide to Manners & Etiquette, Guide to Theater in the Classroom, Guide to Reading Comprehension Strategies.

      • Trusted Partner
      • Fiction
        April 2023

        Rose Addams

        by Margie Taylor

        Rose Addams is hitting her sixties, but these days it feels like they’re starting to hit back ... Rose’s daughter, Morgan, has ditched her thesis program and moved back home to Vancouver, while her son Jason’s partner has never seen eye to eye with his mother. Her husband Charles has decided to take early retirement from the university to work on his long-gestating book, and his rakish best friend Garnet has a new mistress who is way too young for their social circle. When Rose encounters a young man panhandling outside of her library office though, a chain of events is set in motion whereby Rose will have to confront all the facets of her rapidly-complicating life... Recalling the work of Caroline Adderson, Krista Foss, and Marie-Renée Lavoie, Margie Taylor’s Rose Addams is an insight into the life of a woman who is in the process of beginning her third act, an empathetic and incisive look at the problems of those just exiting middle age while attempting to keep up with a rapidly-changing world.

      • Mystery
        2014

        Dinner and Death

        A Carolina Pennsbury Mystery

        by Helen Grochmal

        Who would try to poison a helpless cat in an old folks’ home?  Is it a prank? An accident?  Or something more sinister? Buckingham Courte’s own Carolina Pennsbury is just the amateur sleuth to find out.  As the beautiful cat Apolonia is owned by her friend Margie, one of the Courte’s most pitiful and harrassed residents, Carolina suspects that the poison was actually intended for Margie, so she gathers all of her investigative powers to determine the evil mind behind the devilish plot and to protect her friend until she is able to bring the culprit to justice.  She soon narrows the field of poisoner candidates down to three new residents who have filled an empty seat at the table where Carolina, Margie, and their three friends––Annie, Rita, and Dot––all dine regularly.  Could the potential murderer be the lacivious Mike who can’t seem to keep his hands off any of the Courte’s female residents?  Could it be frigid Frieda who finds Margie’s behavior, appearance, and background totally tasteless?  Or could it be the polite but boring Paula who has all the personality of the chair she occupies?  This may be Carolina’s toughest case––a case of of DINNER AND DEATH.

      • Mystery
        2013

        Manners and Murder

        A Carolina Pennsbury Mystery

        by Helen Grochmal

        Retired librarian Carolina Pennsbury is quite content living in a retirement home.   She just wishes that her meal time tablemates felt as she did.  However, all seem to have their own complaints.  But those complaints are put on the back burner when one of the retirement home’s residents is stabbed to death in her apartment and the police arrest one of Carolina’s tablemates, Margie, for the murder.  Carolina, knowing her friend cannot possibly have committed such a deed, sets about to prove Margie’s innocence––a difficult feat for an elderly woman with a cane.  Knowing the real killer is probably still roaming the halls, Carolina uses her wits and her wit to investigate, and ultimately––after a fake fire alarm and a lengthy blackout––manages to ferret out the killer.  But clearing Margie and getting her out of jail is not the end of Carolina’s tasks.  She has work to do for all of her tablemates and she won’t quit until they are all happy.

      • Teachers' classroom resources & material
        June 1992

        Changing Places

        A Kid's View of Shelter Living

        by Chalofsky, Margie

        Art Across the Alphabet contains art-centered activities for children ages three to six to reinforce letter recognition, build phonemic awareness and pre-reading skills, and associate reading with FUN! The book links art and literacy seamlessly, explores the magic of language, and offers unique opportunities to create readers while creating art--from Airplane wings to Zany Zoo Animals!

      • Oncology
        October 2006

        Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment

        The State of the Science, Evaluation, Implementation, and Economics - Workshop Summary

        by Margie Patlak and Sharyl Nass, Rapporteurs

        Research has long sought to identify biomarkers that could detect cancer at an early stage, or predict the optimal cancer therapy for specific patients. Fueling interest in this research are recent technological advances in genomics, proteomics, and metabolomics that can enable researchers to capture the molecular fingerprints of specific cancers and fine-tune their classification according to the molecular defects they harbor. The discovery and development of new markers of cancer could potentially improve cancer screening, diagnosis, and treatment. Given the potential impact cancer biomarkers could have on the cost effectiveness of cancer detection and treatment, they could profoundly alter the economic burden of cancer as well. Despite the promise of cancer biomarkers, few biomarker-based cancer tests have entered the market, and the translation of research findings on cancer biomarkers into clinically useful tests seems to be lagging. This is perhaps not surprising given the technical, financial, regulatory, and social challenges linked to the discovery, development, validation, and incorporation of biomarker tests into clinical practice. To explore those challenges and ways to overcome them, the National Cancer Policy Forum held the conference "Developing Biomarker-Based Tools for Cancer Screening, Diagnosis and Treatment: The State of the Science, Evaluation, Implementation, and Economics" in Washington, D.C., from March 20 to 22, 2006. At this conference, experts gave presentations in one of six sessions. In addition, seven small group discussions explored the policy implications surrounding biomarker development and adoption into clinical practice. Developing Biomarker-based Tools for Developing Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics-Workshop Summary presents the conference proceedings and will be used by an Institute of Medicine (IOM) committee to develop consensus-based recommendations for moving the field of cancer biomarkers forward.

      • Oncology
        May 2008

        Improving the Quality of Cancer Clinical Trials

        Workshop Summary

        by Margie Patlak and Sharyl Nass, Rapporteurs

        Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: (1) better inform decisions and plans of those responsible for developing new cancer therapies (2) more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic (3) be less costly than current trials The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.

      • Oncology
        April 2009

        Ensuring Quality Cancer Care Through the Oncology Workforce

        Sustaining Care in the 21st Century: Workshop Summary

        by Margie Patlak and Laura Levit, Rapporteurs

        The American Society of Clinical Oncology (ASCO) predicts that by 2020, there will be an 81 percent increase in people living with or surviving cancer, but only a 14 percent increase in the number of practicing oncologists. As a result, there may be too few oncologists to meet the population's need for cancer care. To help address the challenges in overcoming this potential crisis of cancer care, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened the workshop Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century in Washington, DC on October 20 and 21, 2008.

      • Oncology
        December 2008

        Implementing Colorectal Cancer Screening

        Workshop Summary

        by Margie Patlak, Christine Micheel, and Robert German, Rapporteurs

        The IOM's National Cancer Policy Board estimated in 2003 that even modest efforts to implement known tactics for cancer prevention and early detection could result in up to a 29 percent drop in cancer deaths in about 20 years. The IOM's National Cancer Policy Forum, which succeeded the Board after it was disbanded in 2005, continued the Board's work to outline ways to increase screening in the U.S. On February 25 and 26, 2008, the Forum convened a workshop to discuss screening for colorectal cancer. Colorectal cancer screening remains low, despite strong evidence that screening prevents deaths. With the aim to make recommended colorectal cancer screening more widespread, the workshop discussed steps to be taken at the clinic, community, and health system levels. Workshop speakers, representing a broad spectrum of leaders in the field, identified major barriers to increased screening and described strategies to overcome these obstacles. This workshop summary highlights the information presented, as well as the subsequent discussion about actions needed to increase colorectal screening and, ultimately, to prevent more colorectal cancer deaths.

      • Oncology
        February 2010

        Policy Issues in the Development of Personalized Medicine in Oncology

        Workshop Summary

        by Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine

        One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues. To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulation of, and reimbursement for the predictive tests that underpin personalized medicine. Participants discussed the obstacles and possible solutions to further developing and using personalized medicine technologies. This document summarizes the workshop.

      • Oncology
        July 2010

        A Foundation for Evidence-Driven Practice

        A Rapid Learning System for Cancer Care: Workshop Summary

        by Sharon Murphy and Margie Patlak, Rapporteurs; Institute of Medicine

        The IOM's National Cancer Policy Forum held a workshop October 5-6, 2009, to examine how to apply the concept of a 'rapid learning health system' to the problem of cancer. This document summarizes the workshop.

      • Oncology
        August 2011

        Patient-Centered Cancer Treatment Planning

        Improving the Quality of Oncology Care: Workshop Summary

        by Margie Patlak, Erin Balogh, and Sharyl Nass, Rapporteurs; Institute of Medicine

        Each year approximately 1.5 million people are diagnosed with cancer in the United States, most of whom inevitably face difficult decisions concerning their course of care. Recognizing challenges associated with cancer treatment, the National Coalition for Cancer Survivorship (NCCS) and the National Cancer Policy Forum (NCPF) of the Institute of Medicine (IOM) hosted a public workshop in Washington, DC on February 28 and March 1, 2011, entitled Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care. This workshop summary includes an overview of patient-centered care and cancer treatment planning, as well as subject areas on shared decision making, communication in the cancer care setting, and patient experiences with cancer treatment. Best practices, models of treatment planning, and tools to facilitate their use are also discussed, along with policy changes that may promote patient-centeredness by enhancing patient's understanding of and commitment to the goals of treatment through shared decision-making process with their healthcare team from the moment of diagnosis onward. Moreover, Patient-Centered Cancer Treatment Planning emphasizes treatment planning for patients with cancer at the time diagnosis.

      • Paediatric medicine
        April 2002

        Is Soccer Bad for Children's Heads?

        Summary of the IOM Workshop on Neuropsychological Consequences of Head Impact in Youth Soccer

        by Margie Patlak and Janet E. Joy, Board on Neuroscience and Behavioral Health

        To explore whether soccer playing puts youths at risk for lasting brain damage, the Institute of Medicine brought together experts in head injury, sports medicine, pediatrics, and bioengineering. In a workshop entitled "Youth Soccer: Neuropsychological Consequences of Head Impact in Sports," that was held in Washington D.C. on October 12, 2001, these experts presented the scientific evidence for long-term consequences of head injury from youth sports, especially soccer, possible approaches to reduce the risks, and policy issues raised by the subject. Some of the findings presented by the speakers raised concerns, such as the high concussion rate of high school soccer players, the frequent persistence of impaired brain functions even after other symptoms of a concussion disappear, and the need for a better understanding of when it is safe for players to resume playing after they have had a concussion. But other findings were reassuring, such as studies that suggest that with the type of soccer balls used in the United States, heading is not likely to cause brain injury in youths, nor is playing soccer likely to cause permanent brain damage. This is a summary of the reports from these experts in the field, and the lively discussions that followed them. Topics covered include: causes of head injuries in soccer; how to detect a concussion; the biology of concussion; studies of soccer and football players; the role of protective headgear; and policy implications, such as how to decide when a concussed player should be allowed to return to the playing field.

      • Oncology
        September 2010

        Extending the Spectrum of Precompetitive Collaboration in Oncology Research

        Workshop Summary

        by Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; Institute of Medicine

        Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative approaches to drug development, if we are to continue to improve clinical care and reduce mortality. These challenges create opportunities for improved collaboration between industry, academia, government, and philanthropic organizations at each stage in new drug development, marketing, and implementation. Perhaps the most appropriate initial step in addressing the need for collaboration is to consider more precompetitive relationships that allow sharing of scientific information to foster drug development. While these collaborative relationships in basic and preclinical research on drug targets and the early stages of clinical testing are acknowledged to be potentially important drivers for innovation and more rapid marketing of new agents, they also raise a number of concerns that must be addressed. For example, acknowledgment of academic productivity and independence and economic competitiveness must be considered and these challenges managed to foster a culture of collaboration. At the same time, regulatory issues, the need for standardization, and intellectual property concerns must be confronted if the current models for drug development are to be refined to encourage robust participation in precompetitive collaborations. Recognizing the growing importance of precompetitive collaborations in oncology drug development, as well as the challenges these innovative collaborations pose, the National Cancer Policy Forum of the Institute of Medicine held a workshop on February 9 and 10, 2010. This book is a summary of the workshop proceedings.

      • Oncology
        February 2012

        Facilitating Collaborations to Develop Combination Investigational Cancer Therapies

        Workshop Summary

        by Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine

        Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies.

      • Oncology
        May 2011

        The National Cancer Policy Summit

        Opportunities and Challenges in Cancer Research and Care: Workshop Summary

        by Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; National Cancer Policy Forum; Institute of Medicine

        Many ongoing changes are likely to have an impact on cancer research and care. For example, technological advances are rapidly changing the way cancer research is conducted, and the recently passed healthcare reform legislation has many implications for cancer care. Technological advances are altering the way cancer research is conducted and cancer care is delivered, and the recently passed healthcare reform legislation has many implications for cancer care. There is a growing emphasis on molecularly targeted therapies, information technology (IT), and patient-centered care, and clinical cancer research has become a global endeavor. At the same time, there are concerns about shrinking research budgets and escalating costs of cancer care. Considering such changes, the National Cancer Policy Forum (NCPF) of the Institute of Medicine held a National Cancer Policy Summit on October 25, 2010. The Summit convened key leaders in the cancer community to identify and discuss the most pressing policy issues in cancer research and cancer care. The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care is a summary of the summit. The report explores policy issues related to cancer research, the implementation of healthcare reform, delivery of cancer care, and cancer control and public health needs. Expert participants suggested many potential actions to provide patient-centered cancer care, to foster more collaboration, and to achieve other goals to improve research and care.

      Subscribe to our

      newsletter